静脉血栓栓塞:当前的见解和未来的方向
Sahar Mahani1, Michael V DiCaro2, Nadia Tak3
1Department of Cardiovascular Medicine, Kirk Kerkorian SOM at the University of Nevada, Las Vegas, Nevada.
概括
静脉血栓栓塞 (VTE) 是一个全球性的健康问题,在全球范围内呈现出不同的发病率. 本综述详细介绍了包括癌症在内的VTE风险因素,并探讨了潜在的分子机制.
科学领域:
- 心血管医学 心血管医学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 静脉血栓塞栓症 (VTE) 是一个重要的全球健康问题,在全球排名为死亡的第三大原因.
- 与东方国家相比,VTE发病率显示出相当大的地理差异,西方国家报告的发病率更高 (每1000人/年1-2%),而东方国家则较高 (每1000人/年<1).
研究的目的:
- 综合综合审查和综合各种风险因素与静脉血栓塞栓相关的风险因素.
- 探索VTE发展背后的潜在分子机制.
- 突出不同类型癌症中静脉瘤发病率的差异.
主要方法:
- 这项研究是一个全面的文献综述.
- 数据是从有关VTE流行病学和风险因素的现有研究中综合的.
- 专注于确定常见和新出现的VTE风险因素及其分子基础.
主要成果:
- 确定的关键VTE风险因素包括性别,糖尿病,肥胖,吸烟,遗传突变,荷尔蒙影响,长时间旅行,感染,创伤和各种类型的癌症.
- 在胰腺,肝脏和非小细胞肺癌患者中,静脉瘤发病率明显较高,而在乳腺癌,黑色素瘤和前列腺癌患者中则较低.
- 该综述提供了对导致VTE病变的分子机制的见解.
结论:
- 了解VTE的多方面的风险因素对于有效的预防和管理策略至关重要.
- 特定癌症与VTE风险之间的关联需要进一步研究针对性治疗方法.
- 对VTE分子机制的进一步研究可以导致新的治疗和预防方式.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Venous Return
3.1K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
3.1K
Overview of Systemic Veins
439
Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
439
Disorders of Hemostasis
716
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46


